Japanese Companies' Contribution against COVID-19
by IPs
It is known that IP rights are used to challenge competitors so
as to keep them in check or for the monopolizing technologies.
However, the current adverse situations caused by the COVID-19
pandemic have brought change to the way Japanese companies think.
Through the need to develop and manufacture therapeutic medicines,
vaccines, medical devices, infection prevention products to prevent
the further spread of COVID-19 in the current situation through
swift and unconventional ways, many Japanese companies have been
taking actions to release their own patents under the “OPEN
COVID-19 DECLARATION (OCD)” project.
There are 90 companies who have announced their involvement in
the OCD and there are over 910,000 patents available for use (as of
June 30, 2020) and the number is still increasing.